(Total Views: 390)
Posted On: 01/24/2021 1:22:52 PM
Post# of 148905
"Will its apparently stronger safety profile be a winner in cancer and immunomodulatory diseases like Covid?
Read More: https://investorshangout.com/post/view?id=602...3Rmt"
Yes, if there are two drugs that both have similar results in cancer, the one without a black box warning would be preferred.
Read More: https://investorshangout.com/post/view?id=602...3Rmt"
Yes, if there are two drugs that both have similar results in cancer, the one without a black box warning would be preferred.
(0)
(0)Scroll down for more posts ▼
